Longer-term mortality and kidney outcomes of participants in the combination antibiotics for methicillin-resistant Staphylococcus aureus (CAMERA2) trial: a post hoc analysis

• المؤلفون الرئيسيون: Legg, Amy, Roberts, Matthew A., Davies, Jane, Cass, Alan, Meagher, Niamh, Sud, Archana, Daitch, Vered, Dishon Benattar, Yael, Yahav, Dafna, Paul, Mical, Chen, Xinxin, Yeo, He Ping, Lye, David C., Lee, Russel, Robinson, J. Owen, Foo, Hong, Tramontana, Adrian R., Bak, Narin, Grenfell, Adelaide, Rogers, Benjamin, Li, Ying, Joshi, Neela, O'Sullivan, Matthew, McKew, Genevieve, Ghosh, Niladri, Schneider, Kellie, Holmes, Natasha E., Dotel, Ravindra, Chia, Timothy, Archuleta, Sophia, Smith, Simon, Warner, Morgyn S., Titin, Christina, Kalimuddin, Shirin, Roberts, Jason A., Tong, Steven Y. C., Davis, Joshua S.
• مؤلفون آخرون: Lee Kong Chian School of Medicine (LKCMedicine)
• التنسيق: مقال
• اللغة: English
• منشور في: 2023
• الموضوعات: Science::Medicine; Acute Kidney Injury; Nephrotoxicity
• الوصول للمادة أونلاين: https://hdl.handle.net/10356/171771
• المؤسسة: Nanyang Technological University

Background: The Combination Antibiotic Therapy for Methicillin-Resistant Staphylococcus aureus (CAMERA2) trial ceased recruitment in July 2018, noting that a higher proportion of patients in the intervention arm (combination therapy) developed acute kidney injury (AKI) compared to the standard thera...